Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA

Heijde, D. van der; Dougados, M.; Landewe, R.; Sieper, J.; Maksymowych, W.P.; Rudwaleit, M.; ... ; Deodhar, A. (2017)

Article / Letter to editor

• axial spondyloarthritis
• ankylosing spondylitis
• non-radiographic axial spondyloarthritis
• certolizumab pegol

• All authors: Heijde, D. van der; Dougados, M.; Landewe, R.; Sieper, J.; Maksymowych, W.P.; Rudwaleit, M.; Bosch, F. van den; Braun, J.; Mease, P.J.; Kivitz, A.J.; Walsh, J.; Davies, O.; Bauer, L.; Hoepken, B.; Peterson, L.; Deodhar, A.
• Date: 2017-09-30
• Journal: Rheumatology
• Volume: 56
• Issue: 9
• Pages: 1498 - 1509
• DOI: doi:10.1093/rheumatology/kex174